← Back to Search

Motivational Interviewing for Suicidal Thoughts (MI-SI Trial)

N/A
Recruiting
Led By Peter C. Britton, PhD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 and over
English speaking and reading
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-month
Awards & highlights

MI-SI Trial Summary

This trial will test whether a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) can help reduce the risk for suicide attempts and suicidal ideation among Veterans when compared to high quality usual care.

Who is the study for?
This trial is for Veterans over 18 who've recently attempted suicide or have severe suicidal thoughts. They must be English-speaking, able to understand the study, and give informed consent. It's not for those with active mania, current psychosis, dementia, or impaired decision-making capacity.Check my eligibility
What is being tested?
The trial tests a revised motivational interviewing technique (MI-SI-R) against enhanced usual care in reducing suicide risk among Veterans. Participants are randomly assigned to one of these two approaches to compare effectiveness.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, discussing sensitive topics like suicidal ideation may cause emotional discomfort.

MI-SI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can speak and read English.

MI-SI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Beck Scale for Suicidal Ideation
Columbia-Suicide Severity Rating Scale

MI-SI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)Experimental Treatment2 Interventions
Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) was developed to help Veterans resolve ambivalence about living by increasing the motivation to live, and is delivered in three sessions in person, virtually, or by telephone.
Group II: Enhanced usual care (EUC)Active Control1 Intervention
Enhanced usual care (EUC) includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,305,959 Total Patients Enrolled
Syracuse VA Medical CenterFED
13 Previous Clinical Trials
699 Total Patients Enrolled
Portland VA Medical CenterFED
41 Previous Clinical Trials
6,872 Total Patients Enrolled

Media Library

Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) Clinical Trial Eligibility Overview. Trial Name: NCT05256940 — N/A
Suicidal Thoughts Research Study Groups: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R), Enhanced usual care (EUC)
Suicidal Thoughts Clinical Trial 2023: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) Highlights & Side Effects. Trial Name: NCT05256940 — N/A
Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05256940 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies for those seeking to enter this research program?

"The data available through clinicaltrials.gov attests to the fact that, as of 11/23/2022, this study is no longer seeking participants. Nonetheless, there are over two hundred more trials actively recruiting right now."

Answered by AI
~248 spots leftby Nov 2025